13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q3 2024 · Filed November 7, 2024 · Accession 0001104659-24-115326
Total Value
$51.4M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TOURMALINE BIO INC | 89157D105 | 741,691 | $19.1M | 37.12% |
| 2 | JASPER THERAPEUTICS INC | JSPRW | 928,964 | $17.5M | 34.02% |
| 3 | KORRO BIO INC | KRRO | 368,085 | $12.3M | 23.95% |
| 4 | HILLEVAX INC | 43157M102 | 558,923 | $983,704 | 1.92% |
| 5 | VENTYX BIOSCIENCES INC | 92332V107 | 412,225 | $898,651 | 1.75% |
| 6 | KEZAR LIFE SCIENCES INC | KZR | 828,711 | $638,107 | 1.24% |